title: Itraconazole in leukemic patients with invasive aspergillosis (IA): impact on intensive chemotherapy completion.
authors.forename: A
authors.initials: A
authors.lastname: Nosari
authors.forename: S
authors.initials: S
authors.lastname: Cantoni
authors.forename: G
authors.initials: G
authors.lastname: Muti
authors.forename: R
authors.initials: R
authors.lastname: Cairoli
authors.forename: D
authors.initials: D
authors.lastname: Cipriani
authors.forename: F
authors.initials: F
authors.lastname: de Cataldo
mesh_terms: D000328:Adult; D001228:Aspergillosis / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control*; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use*; D007938:Leukemia / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged
chemical_list: D003561:Cytarabine; D017964:Itraconazole; D003630:Daunorubicin